Big pharma’s search for a COVID-19 vaccine: Take It To The Limit!

##plugins.themes.bootstrap3.article.main##

Elina Gaile-Sarkane

Abstract

The 2020 COVID-19 pandemic undermines the world economy, the affordability and accessibility of our health systems.  It puts an increasing strain on global production, supply and value chains.  The research and development of a set of COVID-19 vaccines is an unprecedented triumph of rapid innovation.  The sense of urgency has prompted academic research institutions, big pharmaceuticals and dedicated biotechnology companies to develop vaccines targeting the SARS-CoV-2 coronavirus disease.  Simultaneously, it unlocks new value for business, patients and society.  Consequently, new business models have come to the forefront.

##plugins.themes.bootstrap3.article.details##

Author Biography

Jean-Pierre Segers

visiting professor Riga Technical University

visiting professor Hasselt University

Collaborateur scientific Université de Liège